Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Leitzmann MF, Ahn J, Albanes D, Hsing AW, Schatzkin A, Chang SC, Huang WY, Weiss JM, Danforth KN, Grubb RL 3rd, Andriole GL; Prostate, Lung, Colorectal, and Ovarian Trial Project Team.

Cancer Causes Control. 2008 Dec;19(10):1267-76. doi: 10.1007/s10552-008-9198-6. Epub 2008 Jul 10.

PMID:
18618278
2.

Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Schröder FH.

Can J Urol. 2005 Feb;12 Suppl 1:2-6; discussion 92-3. Review.

PMID:
15780157
3.

Prostate cancer screening: what we have learned from the PLCO and ERSPC trials.

La Rochelle J, Amling CL.

Curr Urol Rep. 2010 May;11(3):198-201. doi: 10.1007/s11934-010-0109-5. Review.

PMID:
20425627
4.

[Early detection of cancer of the prostate. Pros and cons].

Hoesl CE, Altwein JE.

MMW Fortschr Med. 2005 Apr 7;147(14):32, 34-6. Review. German.

PMID:
15887681
5.

Positive association between resting pulse and cancer incidence in current and former smokers.

Cerhan JR, Pavuk M, Wallace RB.

Ann Epidemiol. 1999 Jan;9(1):34-44. Review.

PMID:
9915607
6.

Glycemic index, glycemic load, and chronic disease risk--a meta-analysis of observational studies.

Barclay AW, Petocz P, McMillan-Price J, Flood VM, Prvan T, Mitchell P, Brand-Miller JC.

Am J Clin Nutr. 2008 Mar;87(3):627-37. Review.

7.

Randomized trial results did not resolve controversies surrounding prostate cancer screening.

Hoffman RM.

Curr Opin Urol. 2010 May;20(3):189-93. doi: 10.1097/MOU.0b013e3283383b55. Review.

PMID:
20224414
8.

Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence.

Pierce BL.

Urol Oncol. 2012 Sep;30(5):735-43. doi: 10.1016/j.urolonc.2012.07.008. Review.

PMID:
23021557
9.

Active surveillance for prostate cancer: a review.

Klotz L.

Curr Urol Rep. 2010 May;11(3):165-71. doi: 10.1007/s11934-010-0110-z. Review.

PMID:
20425623
10.

Prostate cancer screening. Why the controversy?

Walther PJ.

Surg Oncol Clin N Am. 1995 Apr;4(2):315-34. Review.

PMID:
7540938
11.

Population screening for prostate cancer: an overview of available studies and meta-analysis.

Lumen N, Fonteyne V, De Meerleert G, Ost P, Villeirs G, Mottrie A, De Visschere P, De Troyer B, Oosterlinck W.

Int J Urol. 2012 Feb;19(2):100-8. doi: 10.1111/j.1442-2042.2011.02912.x. Epub 2011 Nov 22. Review.

12.

Systematic review of prostate cancer's association with body size in childhood and young adulthood.

Robinson WR, Poole C, Godley PA.

Cancer Causes Control. 2008 Oct;19(8):793-803. doi: 10.1007/s10552-008-9142-9. Epub 2008 Mar 18. Review.

PMID:
18347923
13.

Are findings from studies of obesity and prostate cancer really in conflict?

Freedland SJ, Giovannucci E, Platz EA.

Cancer Causes Control. 2006 Feb;17(1):5-9. Review.

PMID:
16411047
14.

The epidemiology of prostate cancer part I: descriptive epidemiology.

Brawley OW, Knopf K, Merrill R.

Semin Urol Oncol. 1998 Nov;16(4):187-92. Review.

PMID:
9858324
15.

Prevention of non-insulin-dependent diabetes mellitus with physical activity.

Helmrich SP, Ragland DR, Paffenbarger RS Jr.

Med Sci Sports Exerc. 1994 Jul;26(7):824-30. Review.

PMID:
7934754
16.

Physical activity, diabetes, and risk of thyroid cancer: a systematic review and meta-analysis.

Schmid D, Behrens G, Jochem C, Keimling M, Leitzmann M.

Eur J Epidemiol. 2013 Dec;28(12):945-58. doi: 10.1007/s10654-013-9865-0. Epub 2013 Nov 17. Review.

PMID:
24243033
17.

The effect of body mass index on PSA levels and the development, screening and treatment of prostate cancer.

Skolarus TA, Wolin KY, Grubb RL 3rd.

Nat Clin Pract Urol. 2007 Nov;4(11):605-14. Review.

PMID:
17982437
18.

Obesity and prostate cancer: making sense out of apparently conflicting data.

Freedland SJ, Platz EA.

Epidemiol Rev. 2007;29:88-97. Epub 2007 May 3. Review.

PMID:
17478439
19.

Energy imbalance and prostate cancer.

Platz EA.

J Nutr. 2002 Nov;132(11 Suppl):3471S-3481S. Review.

20.

The Prostate Cancer Prevention Trial: design, status, and promise.

Thompson IM, Tangen C, Goodman P.

World J Urol. 2003 May;21(1):28-30. Epub 2003 Feb 14. Review.

PMID:
12756491

Supplemental Content

Support Center